Fibrosis: Clinical Trials

39 trials for Fibrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 12 unknown, 4 active not recruiting, 3 terminated. 39 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 139Completed 16, Unknown 12, Active not recruiting 4, Terminated 3, Recruiting 2, Not yet recruiting 1, Withdrawn 1

Follow Fibrosis: new trials by email Literature Review of Fibrosis trials Research Report on Fibrosis

Trials (filtered) newest first · largest first

All 39 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison Of Effectiveness Of Intralesional Injectioms Of 5 Flourouracil Alone Verses Its Cpmbination With Cryotherapy In The Treatment Of Keloids
Cryotherapy will be done followed by intralesional injection of 5-fluorouracil, Intralesional 5-fluorouracil - Keloids
Early Phase 1RecruitingCombined Military Hospital (CMH) institute of Medical Sciences Bahawalpur Pakistan882025-12-222026-04-24
Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)
Fenofibrate - Primary Biliary Cholangitis (PBC)
Early Phase 1Active not recruitingXijing Hospital of Digestive Diseases152025-03-132026-07-29
Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance
Giapreza - Septic Shock, Cirrhosis
Early Phase 1Active not recruitingThe Cleveland Clinic302024-11-152026-05-05
Effect of PRF & Fractional CO2 Laser in Postburn Hypertrophic Scars
Plasma rich in growth factors (PRGF-Endoret), Fractional CO2 laser assisted PDT - Hypertrophic Scars, Burn Scar Patients
Early Phase 1Not yet recruitingAssiut University302024-11-012024-10-29
A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis
Fenofibrate, UDCA (Ursodeoxycholic acid) - Primary Biliary Cholangitis (PBC)
Early Phase 1CompletedHan Ying302024-09-142026-08-05
Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases
T cell injection targeting CD19 chimeric antigen receptor - Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies
Early Phase 1UnknownPersonGen BioTherapeutics (Suzhou) Co., Ltd.102024-05-142024-05-16
Comparison of Chitosan, Ankaferd and Tranexamic Acid in Dental Extraction in Liver Pre-Transplant Children
tranexamic acid, Ankaferd Blood Stopper, Chitosan - Liver Cirrhosis
Early Phase 1CompletedBritish University In Egypt392023-11-152024-10-18
Losartan in Prevention of Radiation-Induced Heart Failure
Losartan, Radiation Therapy - Breast Cancer, Myocardial Fibrosis
Early Phase 1CompletedMassachusetts General Hospital52023-09-132026-04-06
Clinical Study of Allogeneic Fat Decellularized Active Protein in the Treatment of Pulmonary Fibrosis
Cell Free Fat Extract(CEFFE) - Pulmonary Fibrosis
Early Phase 1Active not recruitingShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University72023-08-142025-09-19
A Dosage-dependent Manner of Botulinum Toxin Type A on the Prevention of Postoperative Scars of Various Anatomic Regions of the Body
Botulinum toxin type A - Scar
Early Phase 1CompletedQilu Hospital of Shandong University502023-03-232025-09-12
Effectiveness of Botulinum Toxin A in Preventing Scar Formation and Initial Exploration of "Optimal Concentration"
Botulinum toxin type A - Scar
Early Phase 1CompletedDezhou Hospital Qilu Hospital of Shandong University502023-03-232024-05-31
Fractional CO2 Laser Fenestration and Steroid Delivery in HS Lesions
Triamcinolone Topical, Fractional Ablative CO2 Therapy, EMLA 5% cream - Scar, Hidradenitis Suppurativa
Early Phase 1UnknownUniversity of Southern California102022-11-012022-10-14
Body Composition Changes After TIPS and Associated Clinical Outcomes
Transjugular Intrahepatic Portosystemic Shunt (TIPS) creation - Cirrhosis, Liver, Sarcopenia
Early Phase 1UnknownOregon Health and Science University222022-05-012023-11-07
Examining the Therapeutic Potential of Botulinum Toxin Type A in the Treatment of Keloids
Botulinum toxin type A, Vehicle - Keloid
Early Phase 1CompletedUniversity of California, San Diego102022-03-112025-11-06
FAPI PET for Lung Fibrosis
68Ga-FAPi-46, Computed Tomography, Positron Emission Tomography - Interstitial Lung Disease, Idiopathic Interstitial Pneumonias
Early Phase 1Active not recruitingUniversity of California, Los Angeles302021-11-162026-08-20
Zinc Oxide Versus Petrolatum Following Skin Surgery
Topical zinc oxide vs. petrolatum post-surgical scars - Surgical Incision, Surgery--Complications
Early Phase 1RecruitingMelissa Pugliano-Mauro302021-09-012026-09-02
68Ga-FAPI PET/CT in Patients With Various Fibrotic Disease
68Ga-FAPI-04 - Fibrosis, Positron-Emission Tomography
Early Phase 1UnknownFirst Affiliated Hospital of Fujian Medical University5002021-04-012023-09-21
Single-dose PK Assessment of Oral Proglumide in Those With Hepatic Impairment
Proglumide - Cirrhosis, Liver
Early Phase 1CompletedGeorgetown University112021-03-302022-03-15
The Clinical Application of Tauroursodeoxycholic Acid in Patients With Liver Fibrosis.
Tauroursodeoxycholic acid, Placebo - Liver Cirrhosis
Early Phase 1UnknownThe First Affiliated Hospital with Nanjing Medical University602021-03-052021-03-09
Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
HP 3He, HP 129Xe, PFP - Lung Transplant, Lung Resection
Early Phase 1TerminatedThunder Bay Regional Health Research Institute102020-11-102024-10-15

Showing 20 of 39. Sign in to see all of them.

Narrower conditions

Cicatrix (8)  ·  Liver Cirrhosis (8)  ·  Pulmonary Fibrosis (5)  ·  Keloid (4)  ·  Liver Cirrhosis, Biliary (4)  ·  Cicatrix, Hypertrophic (3)  ·  Lung Diseases, Interstitial (2)  ·  Lung Neoplasms (2)  ·  Acne Vulgaris (1)  ·  Acute Kidney Injury (1)  ·  Alveolitis, Extrinsic Allergic (1)  ·  Arthritis, Rheumatoid (1)  ·  Asbestosis (1)  ·  Asthma (1)

Broader conditions

Pathologic Processes (39)  ·  Pathological Conditions, Signs and Symptoms (39)  ·  Digestive System Diseases (14)  ·  Liver Diseases (13)  ·  Skin and Connective Tissue Diseases (8)  ·  Cicatrix (7)  ·  Lung Diseases (6)  ·  Respiratory Tract Diseases (6)  ·  Connective Tissue Diseases (5)  ·  Liver Cirrhosis (5)  ·  Bile Duct Diseases (4)  ·  Biliary Tract Diseases (4)  ·  Cholestasis (4)  ·  Cholestasis, Intrahepatic (4)

Interventions

Sodium Chloride (4)  ·  Botulinum Toxins, Type A (3)  ·  68Ga-FAPI (2)  ·  Fenofibrate (2)  ·  4-((5-chloro-2-pyridinyl)oxy)-1-((((4S)-4-methyl-2,5-dioxo-4-imidazolidinyl)methyl)sulfonyl)-piperidine (1)  ·  Chitosan (1)  ·  Ciprofloxacin (1)  ·  Epinephrine (1)  ·  Ethanol (1)  ·  FAPI-46 (1)  ·  Facility Design and Construction (1)  ·  Giapreza (1)  ·  High-Energy Shock Waves (1)  ·  Hyaluronic Acid (1)  ·  Hydroxychloroquine (1)

Sponsors

First Affiliated Hospital of Fujian Medical University (2)  ·  Massachusetts General Hospital (2)  ·  Peking Union Medical College Hospital (2)  ·  University of California, Los Angeles (2)  ·  Assiut University (1)  ·  British University In Egypt (1)  ·  Chandan K Sen (1)  ·  Changhai Hospital (1)  ·  Chinese University of Hong Kong (1)  ·  Combined Military Hospital (CMH) institute of Medical Sciences Bahawalpur Pakistan (1)  ·  Dezhou Hospital Qilu Hospital of Shandong University (1)  ·  Georgetown University (1)  ·  Hadassah Medical Organization (1)  ·  Han Ying (1)  ·  Jinnah Postgraduate Medical Centre (1)

Countries

United States (14)  ·  China (11)  ·  Pakistan (2)  ·  Canada (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Finland (1)  ·  Hong Kong (1)  ·  United Kingdom (1)

Top investigators

Zhaohui Zhu, MD (2)  ·  Ahmed Ali, Assistant Proffesor (1)  ·  Ariel Revel, MD (1)  ·  Caroline Kettering, MD (1)  ·  Chandan K Sen, PhD (1)  ·  Chengzhong Li, Dr. (1)  ·  Daniel W Hommes, MD, PhD (1)  ·  David M Zloty, MD (1)  ·  Dean L Kellogg Jr, MD (1)  ·  Jeremie Calais, MD (1)  ·  Jianya Xue, Dr. (1)  ·  Jill P Smith, MD (1)  ·  Kev Dhaliwal, MBChB (1)  ·  Lei Xin, Dr. (1)  ·  Michael Bernhardt, MD (1)

Results publications

PMID 12140476, PMID 19036028, PMID 19293006, PMID 19438670, PMID 20039918, PMID 20166154, PMID 22236226, PMID 22454486, PMID 23460557, PMID 23904820, PMID 25102552, PMID 25396122, PMID 25588037, PMID 26119625, PMID 26470622, PMID 26966160, PMID 27292082, PMID 27688440, PMID 27692735, PMID 28249726, PMID 30087573, PMID 30872156, PMID 30886476, PMID 31604104, PMID 31688123, PMID 32460374, PMID 32717289, PMID 33002270, PMID 33890304, PMID 35160122, PMID 35333217, PMID 35584850, PMID 35762891, PMID 36036977, PMID 39362770, PMID 41805969

NIH funding

P30CA016672 (1), R01CA195524 (1)